Tuesday, December 14, 2021 2:23:29 PM
https://www.zerohedge.com/covid-19/pfizers-covid-bill-stops-hospitalizations-not-milder-symptoms
In addition to making dramatic inroads for patients who are at high risk, the preliminary analysis showed the drug may also help people at low risk of severe COVID - for example, vaccinated patients who fall victim to a breakthrough infection - avoid becoming seriously ill. The data showed the drug reduced risk of hospitalization by 70%, although it failed to reduce or resolve symptoms within three or four days, suggesting it will be of limited use for patients only suffering from mild symptoms.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM